Generex Biotechnology Corporation (OTCMKTS:GNBT) has such a strong portfolio of immune-oncology assets, diagnostics, and medical devices. An acquisition strategy the company applies from time to time...
Generex Biotechnology Corporation’s (OTCMKTS:GNBT) wholly-owned subsidiary NuGenerex Immuno-Oncology launched a vaccine development initiative to address the emerging new pandemic threat from the recently identified Swine flu...
For the last couple of months, the world has experienced panic and disarray from the outbreak and the rapid spread of coronavirus. However, it is now...
